| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 4.21e-05 | 188 | 99 | 7 | GO:0005201 | |
| Domain | - | 1.59e-04 | 4 | 97 | 2 | 3.90.1460.10 | |
| Domain | GTF2I | 1.59e-04 | 4 | 97 | 2 | PS51139 | |
| Domain | GTF2I | 1.59e-04 | 4 | 97 | 2 | PF02946 | |
| Domain | GTF2I | 1.59e-04 | 4 | 97 | 2 | IPR004212 | |
| Domain | Cyt_P450_E_grp-II | 2.64e-04 | 5 | 97 | 2 | IPR002402 | |
| Domain | IG | 3.42e-04 | 421 | 97 | 9 | SM00409 | |
| Domain | Ig_sub | 3.42e-04 | 421 | 97 | 9 | IPR003599 | |
| Domain | Cyt_P450_E_CYP3A | 3.95e-04 | 6 | 97 | 2 | IPR008072 | |
| Domain | - | SEMA3F MXRA5 COL12A1 NRCAM CNTN6 HAVCR1 PTPRS VCAN VSIG10L TRIM36 IGSF21 | 6.47e-04 | 663 | 97 | 11 | 2.60.40.10 |
| Domain | IG_LIKE | 1.03e-03 | 491 | 97 | 9 | PS50835 | |
| Domain | Ig-like_fold | SEMA3F MXRA5 COL12A1 NRCAM CNTN6 HAVCR1 PTPRS VCAN VSIG10L TRIM36 IGSF21 | 1.08e-03 | 706 | 97 | 11 | IPR013783 |
| Domain | A2M_N | 1.17e-03 | 10 | 97 | 2 | PF01835 | |
| Domain | A2M_N | 1.17e-03 | 10 | 97 | 2 | IPR002890 | |
| Domain | A-macroglobulin_rcpt-bd | 1.17e-03 | 10 | 97 | 2 | IPR009048 | |
| Domain | ALPHA_2_MACROGLOBULIN | 1.17e-03 | 10 | 97 | 2 | PS00477 | |
| Domain | A2M | 1.17e-03 | 10 | 97 | 2 | PF00207 | |
| Domain | Adenylat/UMP-CMP_kin | 1.17e-03 | 10 | 97 | 2 | IPR000850 | |
| Domain | A2M_N_2 | 1.17e-03 | 10 | 97 | 2 | IPR011625 | |
| Domain | A2M_comp | 1.17e-03 | 10 | 97 | 2 | IPR011626 | |
| Domain | A2M_N_2 | 1.17e-03 | 10 | 97 | 2 | PF07703 | |
| Domain | A2M_recep | 1.17e-03 | 10 | 97 | 2 | PF07677 | |
| Domain | A2M_comp | 1.17e-03 | 10 | 97 | 2 | PF07678 | |
| Domain | Macroglobln_a2 | 1.17e-03 | 10 | 97 | 2 | IPR001599 | |
| Domain | Ig-like_dom | 1.22e-03 | 503 | 97 | 9 | IPR007110 | |
| Domain | IGc2 | 1.42e-03 | 235 | 97 | 6 | SM00408 | |
| Domain | Ig_sub2 | 1.42e-03 | 235 | 97 | 6 | IPR003598 | |
| Domain | fn3 | 1.57e-03 | 162 | 97 | 5 | PF00041 | |
| Domain | FN3 | 2.79e-03 | 185 | 97 | 5 | SM00060 | |
| Domain | IG_MHC | 3.75e-03 | 60 | 97 | 3 | PS00290 | |
| Domain | FN3 | 3.81e-03 | 199 | 97 | 5 | PS50853 | |
| Domain | Terpenoid_cyclase/PrenylTrfase | 3.87e-03 | 18 | 97 | 2 | IPR008930 | |
| Domain | BRCT | 4.31e-03 | 19 | 97 | 2 | PF00533 | |
| Domain | - | 4.50e-03 | 64 | 97 | 3 | 3.40.50.1000 | |
| Domain | FN3_dom | 4.69e-03 | 209 | 97 | 5 | IPR003961 | |
| Pubmed | Comprehensive proteomic characterization of stem cell-derived extracellular matrices. | 1.78e-07 | 86 | 99 | 6 | 28327460 | |
| Pubmed | 5.25e-06 | 153 | 99 | 6 | 25037231 | ||
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 28986474 | ||
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 31545650 | ||
| Pubmed | Differential regulation of CYP3A4 and CYP3A7 by dimethylsulfoxide in primary human hepatocytes. | 8.02e-06 | 2 | 99 | 2 | 15379787 | |
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 15082191 | ||
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 1692292 | ||
| Pubmed | Fyn binds to and phosphorylates T cell immunoglobulin and mucin domain-1 (Tim-1). | 8.02e-06 | 2 | 99 | 2 | 21513984 | |
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 26772622 | ||
| Pubmed | Role of Chromatin Structural Changes in Regulating Human CYP3A Ontogeny. | 8.02e-06 | 2 | 99 | 2 | 26921389 | |
| Pubmed | Molecular mechanisms of polymorphic CYP3A7 expression in adult human liver and intestine. | 8.02e-06 | 2 | 99 | 2 | 11940601 | |
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 19539600 | ||
| Pubmed | Development of CD1d-restricted NKT cells in the mouse thymus. | 8.02e-06 | 2 | 99 | 2 | 15549774 | |
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 17579091 | ||
| Pubmed | Expression of CYP3A4 and CYP3A7 in Human Foetal Tissues and its Correlation with Nuclear Receptors. | 8.02e-06 | 2 | 99 | 2 | 25689036 | |
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 27349315 | ||
| Pubmed | Comparison of TFII-I gene family members deleted in Williams-Beuren syndrome. | 8.02e-06 | 2 | 99 | 2 | 15388857 | |
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 11811950 | ||
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 20571036 | ||
| Pubmed | Developmental regulation of CYP3A4 and CYP3A7 in Chinese Han population. | 8.02e-06 | 2 | 99 | 2 | 27727071 | |
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 12485945 | ||
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 21273439 | ||
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 19801957 | ||
| Pubmed | Metabolic pathways of inhaled glucocorticoids by the CYP3A enzymes. | 2.40e-05 | 3 | 99 | 2 | 23143891 | |
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 33866277 | ||
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 20621111 | ||
| Pubmed | Contribution of three CYP3A isoforms to metabolism of R- and S-warfarin. | 2.40e-05 | 3 | 99 | 2 | 20615193 | |
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 22277676 | ||
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 15100712 | ||
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 12183561 | ||
| Pubmed | Comparison of steroid hormone hydroxylation mediated by cytochrome P450 3A subfamilies. | 2.40e-05 | 3 | 99 | 2 | 32001245 | |
| Pubmed | Alpha-2 macroglobulin controls trophoblast positioning in mouse implantation sites. | 2.40e-05 | 3 | 99 | 2 | 14580373 | |
| Pubmed | UNC119a bridges the transmission of Fyn signals to Rab11, leading to the completion of cytokinesis. | 2.40e-05 | 3 | 99 | 2 | 23535298 | |
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 32146629 | ||
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 8662763 | ||
| Pubmed | alpha2-macroglobulin- and murinoglobulin-1- deficient mice. A mouse model for acute pancreatitis. | 2.40e-05 | 3 | 99 | 2 | 10487856 | |
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 17582393 | ||
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 20118548 | ||
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 34688813 | ||
| Pubmed | Neural cell adhesion molecule NrCAM regulates Semaphorin 3F-induced dendritic spine remodeling. | 2.40e-05 | 3 | 99 | 2 | 25143608 | |
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 4.37e-05 | 135 | 99 | 5 | 28675934 | |
| Pubmed | 4.79e-05 | 4 | 99 | 2 | 9344465 | ||
| Pubmed | 4.79e-05 | 4 | 99 | 2 | 27031383 | ||
| Pubmed | 4.79e-05 | 4 | 99 | 2 | 11564755 | ||
| Pubmed | 4.79e-05 | 4 | 99 | 2 | 29415226 | ||
| Pubmed | 4.79e-05 | 4 | 99 | 2 | 26238215 | ||
| Pubmed | 4.79e-05 | 4 | 99 | 2 | 17823943 | ||
| Pubmed | 4.79e-05 | 4 | 99 | 2 | 23229069 | ||
| Pubmed | 4.79e-05 | 4 | 99 | 2 | 22899722 | ||
| Pubmed | 4.79e-05 | 4 | 99 | 2 | 34689350 | ||
| Pubmed | 4.79e-05 | 4 | 99 | 2 | 18978522 | ||
| Pubmed | Molecular basis for ubiquitin/Fubi cross-reactivity in USP16 and USP36. | 4.79e-05 | 4 | 99 | 2 | 37443395 | |
| Pubmed | 4.79e-05 | 4 | 99 | 2 | 21328569 | ||
| Pubmed | 4.79e-05 | 4 | 99 | 2 | 9166830 | ||
| Pubmed | Novel vertebrate nucleoporins Nup133 and Nup160 play a role in mRNA export. | 4.79e-05 | 4 | 99 | 2 | 11684705 | |
| Pubmed | 4.79e-05 | 4 | 99 | 2 | 1702714 | ||
| Pubmed | Human skeletal muscle drug transporters determine local exposure and toxicity of statins. | 4.79e-05 | 4 | 99 | 2 | 19940267 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | STAM2 EFL1 HYOU1 SF3A1 NUP98 RPS20 TXNRD1 MAP1S SBNO1 NFRKB NUP133 SDF2L1 AHNAK2 RAD23B | 6.46e-05 | 1455 | 99 | 14 | 22863883 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | USP36 STAM2 SF3A1 NUP98 RPS20 USP16 EMSY ZNF512B STAU2 NUP133 AHNAK2 | 7.25e-05 | 934 | 99 | 11 | 33916271 |
| Pubmed | 7.98e-05 | 5 | 99 | 2 | 24168324 | ||
| Pubmed | 7.98e-05 | 5 | 99 | 2 | 14559847 | ||
| Pubmed | Genomic organization of the human CYP3A locus: identification of a new, inducible CYP3A gene. | 7.98e-05 | 5 | 99 | 2 | 11266076 | |
| Pubmed | 7.98e-05 | 5 | 99 | 2 | 7514554 | ||
| Pubmed | Dual functional activity of semaphorin 3B is required for positioning the anterior commissure. | 7.98e-05 | 5 | 99 | 2 | 16202709 | |
| Pubmed | 7.98e-05 | 5 | 99 | 2 | 11093772 | ||
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | 8.33e-05 | 363 | 99 | 7 | 14691545 | |
| Pubmed | 9.69e-05 | 257 | 99 | 6 | 16335952 | ||
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | COL4A3 HYOU1 ASH1L RPS20 TXNRD1 ARHGAP18 NNT UNC79 HYDIN AHNAK2 | 1.04e-04 | 807 | 99 | 10 | 30575818 |
| Pubmed | Genetic mapping of mouse tumor necrosis factor-alpha converting enzyme (TACE) to chromosome 12. | 1.19e-04 | 6 | 99 | 2 | 9598327 | |
| Pubmed | 1.19e-04 | 6 | 99 | 2 | 8170356 | ||
| Pubmed | 1.19e-04 | 6 | 99 | 2 | 18046458 | ||
| Pubmed | Unc119, a novel activator of Lck/Fyn, is essential for T cell activation. | 1.19e-04 | 6 | 99 | 2 | 14757743 | |
| Pubmed | Molecular alterations of the Fyn-complex occur as late events of human T cell activation. | 1.19e-04 | 6 | 99 | 2 | 10229084 | |
| Pubmed | Why do cellular proteins linked to K63-polyubiquitin chains not associate with proteasomes? | 1.30e-04 | 170 | 99 | 5 | 23314748 | |
| Pubmed | The human cytochrome P450 3A locus. Gene evolution by capture of downstream exons. | 1.67e-04 | 7 | 99 | 2 | 11137287 | |
| Pubmed | 1.67e-04 | 7 | 99 | 2 | 19842932 | ||
| Pubmed | 2.22e-04 | 8 | 99 | 2 | 20147896 | ||
| Pubmed | 2.22e-04 | 8 | 99 | 2 | 28637841 | ||
| Pubmed | 2.22e-04 | 8 | 99 | 2 | 21437268 | ||
| Pubmed | 2.34e-04 | 193 | 99 | 5 | 19343046 | ||
| Pubmed | 2.37e-04 | 42 | 99 | 3 | 24997765 | ||
| Pubmed | 2.72e-04 | 44 | 99 | 3 | 31273033 | ||
| Pubmed | Identification of genetic variants associated with response to statin therapy. | 2.85e-04 | 9 | 99 | 2 | 19667110 | |
| Pubmed | Targeted inactivation of the mouse alpha 2-macroglobulin gene. | 2.85e-04 | 9 | 99 | 2 | 7544347 | |
| Pubmed | Cell-cycle-dependent phosphorylation of the nuclear pore Nup107-160 subcomplex. | 2.85e-04 | 9 | 99 | 2 | 17360435 | |
| Pubmed | 3.45e-04 | 210 | 99 | 5 | 16565220 | ||
| Pubmed | 3.54e-04 | 608 | 99 | 8 | 16713569 | ||
| Pubmed | 3.56e-04 | 10 | 99 | 2 | 15146057 | ||
| Pubmed | 3.56e-04 | 10 | 99 | 2 | 20676042 | ||
| Pubmed | 3.56e-04 | 10 | 99 | 2 | 12865317 | ||
| Pubmed | 3.56e-04 | 10 | 99 | 2 | 10744724 | ||
| Pubmed | 3.73e-04 | 613 | 99 | 8 | 22268729 | ||
| Pubmed | 3.75e-04 | 49 | 99 | 3 | 21362503 | ||
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 4.33e-04 | 123 | 99 | 4 | 26912792 | |
| Pubmed | 4.34e-04 | 11 | 99 | 2 | 18619525 | ||
| Pubmed | 4.34e-04 | 11 | 99 | 2 | 19105203 | ||
| Pubmed | Identification and characterization of the potential promoter regions of 1031 kinds of human genes. | 4.47e-04 | 52 | 99 | 3 | 11337467 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | A2M HYOU1 SF3A1 NUP98 RPS20 EMSY TXNRD1 NAA25 STAU2 NNT AHNAK2 RAD23B | 5.11e-04 | 1367 | 99 | 12 | 32687490 |
| Pubmed | A role for Nr-CAM in the patterning of binocular visual pathways. | 5.20e-04 | 12 | 99 | 2 | 16701205 | |
| Pubmed | 5.20e-04 | 12 | 99 | 2 | 15319333 | ||
| GeneFamily | Fibronectin type III domain containing | 3.39e-04 | 160 | 68 | 5 | 555 | |
| GeneFamily | Cytochrome P450 family 3 | 3.85e-04 | 8 | 68 | 2 | 1002 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 4.93e-04 | 9 | 68 | 2 | 1234 | |
| GeneFamily | Immunoglobulin like domain containing | 7.96e-04 | 193 | 68 | 5 | 594 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 3.17e-03 | 161 | 68 | 4 | 593 | |
| Coexpression | LIAO_METASTASIS | SEMA3F HYOU1 NRCAM PCNX3 TSHZ2 TRPC1 ECT2 CABYR SBNO1 VCAN UCP2 VSIG10L | 9.41e-07 | 540 | 99 | 12 | M13809 |
| Coexpression | GSE42021_TREG_VS_TCONV_PLN_DN | 1.08e-05 | 199 | 99 | 7 | M9574 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.32e-10 | 184 | 99 | 9 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.32e-10 | 184 | 99 | 9 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.32e-10 | 184 | 99 | 9 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | RV-01._Fibroblast_I|RV / Chamber and Cluster_Paper | 1.17e-08 | 192 | 99 | 8 | 356160b113c3305a61ceeaff33ce3c9da0be2878 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.47e-07 | 192 | 99 | 7 | 72881b280a415e65f87a80ca1369cbb0b722a0c4 | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.56e-07 | 193 | 99 | 7 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | RV-02._Fibroblast_II|RV / Chamber and Cluster_Paper | 2.65e-07 | 194 | 99 | 7 | 11c79a8c56ece42713b04b321982e41e239f07a5 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.65e-07 | 194 | 99 | 7 | 240d122dcb9dd1ab2867503ad85869853adcacae | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.65e-07 | 194 | 99 | 7 | ae7df037592f1c20c9d32be15fe6fc3c562ebeb1 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.74e-07 | 195 | 99 | 7 | d8ebb94f30d4a655d6b29dd6a3076be2403d2356 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.74e-07 | 195 | 99 | 7 | 44d7bef5f59c2c2bad1392ee6aabdaa5d7f531d9 | |
| ToppCell | RA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 2.84e-07 | 196 | 99 | 7 | e8cbda03837f1f26470a9d93aa7fdaa04e08e38a | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 2.94e-07 | 197 | 99 | 7 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | distal-3-mesenchymal-Myofibroblast|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.14e-07 | 199 | 99 | 7 | 1f20addc0d138fec02ed6ca4c518169c568de263 | |
| ToppCell | ILEUM-inflamed-(8)_Fibroblast-(8)_Fibroblasts|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.14e-07 | 199 | 99 | 7 | 615f20bf136dfef53b072667cf0e4df6a1017e05 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.25e-07 | 200 | 99 | 7 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | nucseq-Immune-Hematopoietic-Granulocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.88e-06 | 165 | 99 | 6 | 37615622c736e43260c38016e7c9e565ac97a3e8 | |
| ToppCell | nucseq-Immune-Hematopoietic-Granulocytic-Mast/Basophil|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.88e-06 | 165 | 99 | 6 | 640bb71e74a61df2fcb01ceeabe4c493ef836b21 | |
| ToppCell | nucseq-Immune-Hematopoietic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.88e-06 | 165 | 99 | 6 | f3df74b5763130c71c0a482a3a23f6b22acc2892 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-plasmacytoid_dendritic_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.94e-06 | 166 | 99 | 6 | 1ca888ae8168707493f19ee52a89d7c70e6cb51d | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-plasmacytoid_dendritic_cell-plasmacytoid_dendritic|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.94e-06 | 166 | 99 | 6 | 4cba4ca1aa2321b9ef7cd230932b890d2434a252 | |
| ToppCell | Bronchial_Biopsy-Immune-Mast_cells|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.08e-06 | 168 | 99 | 6 | 45ccc0cb42d21f4853190e8e9ed9a54aefefe738 | |
| ToppCell | Control-Mast_cells|Control / group, cell type (main and fine annotations) | 2.16e-06 | 169 | 99 | 6 | fdb9abca1d0f4fdc32dd8ac6231651ef34aa5afb | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.23e-06 | 170 | 99 | 6 | fa753cc8fbd04e63c9a303da4dc17ee2ce907f92 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.23e-06 | 170 | 99 | 6 | 03044e1436443b28dd39d5ef4fdb25c18e3a7546 | |
| ToppCell | Control-Mast_cells-Mast_cells|Control / group, cell type (main and fine annotations) | 2.23e-06 | 170 | 99 | 6 | c80f6d29096c372da95a8407f402349ff1bb7018 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.47e-06 | 173 | 99 | 6 | 2b448acd5e584f24567204c31b8d74715e92f32a | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.47e-06 | 173 | 99 | 6 | 5086edc29c5a6137ca09877929a1317f9739c801 | |
| ToppCell | droplet-Spleen-nan-3m-Myeloid-macrophage_dendritic_cell_progenitor|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.64e-06 | 175 | 99 | 6 | 21bc0e59a9509d38751ce6aad2325f341bc70eff | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.64e-06 | 175 | 99 | 6 | d67c77eee979ad029e7545f383326f0ff77c6e5f | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.64e-06 | 175 | 99 | 6 | 1d1cdbf3221b03e24eae38afd57cbd6736b37a53 | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.01e-06 | 179 | 99 | 6 | dcaf2191134a586d50ebaf67dcf5b815b54a722b | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.01e-06 | 179 | 99 | 6 | 87a69f9f83b8f0c028a4874acb238f2e079bf51f | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.11e-06 | 180 | 99 | 6 | fa819df81fca95c2cc602fede635cb03e3f35fad | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.11e-06 | 180 | 99 | 6 | 907cd510fd2e21532ce04ba687e8894f7af71f27 | |
| ToppCell | RA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 3.21e-06 | 181 | 99 | 6 | 2b6ddeb53a79a658e2ba78527ff48c155b20daa6 | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.21e-06 | 181 | 99 | 6 | 782716b8b1d447d2bbe09a693fa5ed7ebeac0efb | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.21e-06 | 181 | 99 | 6 | e2481291c236105774c53883e6f20da11941df9b | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.21e-06 | 181 | 99 | 6 | e6c78038b14100e0c9c6fe25e8f0b75c02c33549 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.31e-06 | 182 | 99 | 6 | b7d532feb73167e05475855061b35a209583f44c | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.31e-06 | 182 | 99 | 6 | af65f0fc3f9e5d9ce69ee5faaf5b6cb7f8412e0c | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.64e-06 | 185 | 99 | 6 | 51dfe6ac7df8b330343b37e3bee71e5c65267189 | |
| ToppCell | droplet-Marrow-nan-21m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.64e-06 | 185 | 99 | 6 | 65dcb0a7ee64990a34a87c167b44497107f035ee | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.64e-06 | 185 | 99 | 6 | a8c02cec3c414f3a0da9f2d6d28ce563b0030705 | |
| ToppCell | COPD-Myeloid-Mast|COPD / Disease state, Lineage and Cell class | 3.75e-06 | 186 | 99 | 6 | def6f0f284acc2154738574c8c5d3d2a5ef1f208 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.75e-06 | 186 | 99 | 6 | 4e94158db52df41d71e67b02b9895a358eebee0f | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.87e-06 | 187 | 99 | 6 | 201ff693e4756ee3e44762885b3a303a77eb535b | |
| ToppCell | Monocytes-M2-like_CD16+_macrophages|Monocytes / Immune cells in Kidney/Urine in Lupus Nephritis | 3.87e-06 | 187 | 99 | 6 | 59e31c51183ed4c9a3d0792c8005ea3a12b28dfa | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.87e-06 | 187 | 99 | 6 | c104fbfef2d0bef64077ac721edf2379fd59d547 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.99e-06 | 188 | 99 | 6 | a244fcd092d5bd544e503366b1439b0fbc1ee00e | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.99e-06 | 188 | 99 | 6 | 997dcfc4f08738ab398d8abc15e4fd2fc6619862 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.99e-06 | 188 | 99 | 6 | 006db2c2c44971ca9241c582bc89f258c785f5ed | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.99e-06 | 188 | 99 | 6 | c8530c9ff98666c64a94683261af4288cb790a7e | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.99e-06 | 188 | 99 | 6 | d0e6fb4a3b3d79d3512b5500062ea285495ae526 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Mesenchymal-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.99e-06 | 188 | 99 | 6 | d534ed9870405a3c1075962308f72b460aed17bf | |
| ToppCell | Mesenchymal-myofibroblast_cell|World / Lineage, Cell type, age group and donor | 4.11e-06 | 189 | 99 | 6 | 44e37f88137bb249933eb615235b2cf2ae7f3925 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.24e-06 | 190 | 99 | 6 | 2306aa9dbeaef3be8484a5b236605de23cd75d4c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.24e-06 | 190 | 99 | 6 | 70c86dd454afb21d4a85db56c5f369d4b342bc97 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.24e-06 | 190 | 99 | 6 | 1f83f7f24288a3b9ab33c2e113e845dba96adc8a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.37e-06 | 191 | 99 | 6 | a58c75e9580139fb370b498d95660f10f3a2a27b | |
| ToppCell | droplet-Marrow-BM-1m-Lymphocytic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.37e-06 | 191 | 99 | 6 | 4187f31ec399b4c7c3608e94e3c32b7a54b1c3d4 | |
| ToppCell | RV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 4.37e-06 | 191 | 99 | 6 | 70c067c54084bfb02c29bab085f4defd477194fb | |
| ToppCell | droplet-Marrow-BM-1m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.37e-06 | 191 | 99 | 6 | 8e8bc200524a44ebe132f823ab7c15dac65d4952 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.50e-06 | 192 | 99 | 6 | 9093a9e94a25682d109a7f6edc256a25a61103a0 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.50e-06 | 192 | 99 | 6 | d3c1ad4667a1e223a83ca0fcd5991a0b96f1199a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.50e-06 | 192 | 99 | 6 | 9ed5d49621ec1aa01716dc369bba1450b5f015f5 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.64e-06 | 193 | 99 | 6 | f1199518c3626fd29bfce65070dd21a660671213 | |
| ToppCell | LV-01._Fibroblast_I|LV / Chamber and Cluster_Paper | 4.64e-06 | 193 | 99 | 6 | dc17f3b9758936d428cf17f77a1ce6d4c479b165 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.64e-06 | 193 | 99 | 6 | 261cafc167c86ab277be4ea7f08b0173e2dde26e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.78e-06 | 194 | 99 | 6 | ebb038f94f49f5c655578d1b018676e10c6b7e3c | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.92e-06 | 195 | 99 | 6 | d9a5c75d31c6e8bb1e1ab7fd115ac5deb5fb1c8d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.92e-06 | 195 | 99 | 6 | 49c99553629cdd83ee56a2e508d5bc8d34b8507b | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.92e-06 | 195 | 99 | 6 | 803f714d91f2d97ecbee8c15a5139fd9310f66c7 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.92e-06 | 195 | 99 | 6 | cad6563cc51d212554152c727fc2c249c6a07e4d | |
| ToppCell | LA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 4.92e-06 | 195 | 99 | 6 | a78b605b49acd8c9d68716266ca269dafcd910b9 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.92e-06 | 195 | 99 | 6 | dd281a249854800f737dc22e0f375f66dfb5cf5f | |
| ToppCell | RV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 4.92e-06 | 195 | 99 | 6 | ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.92e-06 | 195 | 99 | 6 | 783bfa8110161cbd6def50ce849cae676c39c458 | |
| ToppCell | RA-02._Fibroblast_II|RA / Chamber and Cluster_Paper | 4.92e-06 | 195 | 99 | 6 | 6a02ebbeb3199447ddce64d92d8809436e040eba | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.92e-06 | 195 | 99 | 6 | 4f70157d42a16ff0259bc24a62803c4df4285c44 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.07e-06 | 196 | 99 | 6 | b8759e6231e0254797d6c30930407b79440c57bb | |
| ToppCell | IPF-Endothelial-VE_Capillary_B|Endothelial / Disease state, Lineage and Cell class | 5.07e-06 | 196 | 99 | 6 | 8f0f72ead06abe02b575e443552eacc2151077ef | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.07e-06 | 196 | 99 | 6 | 2b36b9a40fe415917afccff99ad9c3474e087d0d | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.07e-06 | 196 | 99 | 6 | ba869f7a86f37fd6d84d6ad69baca0e0faaf5887 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.07e-06 | 196 | 99 | 6 | 30ad56d49000e4ddce73b4443b3994564bd1e2d6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.07e-06 | 196 | 99 | 6 | 3a6c942e2907aa07b5e12dbf9019d18f7bfca507 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.07e-06 | 196 | 99 | 6 | bba88e91cd3e3a6f5a9b443e3a4da33c5b455e70 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.22e-06 | 197 | 99 | 6 | 6d027119a5f7ca2aac1b10837e43f9a2bb54db85 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.22e-06 | 197 | 99 | 6 | 4cf4e9553397cd8dee883dbec24f41bec41aff99 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.22e-06 | 197 | 99 | 6 | 80e153790cef37b743e22a7370ff5b3a6abf147d | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.22e-06 | 197 | 99 | 6 | 6d0d68d460243a0259ada93ebda40fa7b3088eeb | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.37e-06 | 198 | 99 | 6 | 79576525a10ed3e3a9d1608077cd16ecda23376f | |
| ToppCell | COVID-19-kidney-Fibroblast-2|kidney / Disease (COVID-19 only), tissue and cell type | 5.37e-06 | 198 | 99 | 6 | ca26ca460856b1faaa3e83766da6abdf63af2b51 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.53e-06 | 199 | 99 | 6 | ec74ff85d6b61013b1f785b2fca343759feb7843 | |
| ToppCell | Fibroblasts-CD34+_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 5.53e-06 | 199 | 99 | 6 | 13ff7409e200a0b46cdb7924d15ef33639693622 | |
| ToppCell | ILEUM-inflamed-(8)_Fibroblasts|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 5.53e-06 | 199 | 99 | 6 | 3a3e2bb21cd0293622b1a975263e918d9ba24265 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.53e-06 | 199 | 99 | 6 | 19a97e27a4758e794ce7246d295e112b47931a48 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.53e-06 | 199 | 99 | 6 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | COVID-19-kidney-Fibroblast-1|kidney / Disease (COVID-19 only), tissue and cell type | 5.53e-06 | 199 | 99 | 6 | 9503646ff1ad248181146ce767e9d12e882ec3bd | |
| ToppCell | ILEUM-non-inflamed-(8)_Fibroblast-(8)_Fibroblasts|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 5.53e-06 | 199 | 99 | 6 | 56d72da6a5fab9cbb2975fe6f87a631debaba6a8 | |
| Drug | nateglinide | 2.76e-06 | 7 | 99 | 3 | ctd:C060142 | |
| Disease | Colorectal Carcinoma | ABCC4 ATP7B NRCAM ABCA12 SF3A1 APOB CINP TXNRD1 CABYR PTPRS PZP IGSF21 | 3.02e-06 | 702 | 96 | 12 | C0009402 |
| Disease | Osteoarthritis, Knee | 6.26e-05 | 4 | 96 | 2 | C0409959 | |
| Disease | tacrolimus measurement | 6.26e-05 | 4 | 96 | 2 | EFO_0008458 | |
| Disease | estrone conjugate measurement | 6.26e-05 | 4 | 96 | 2 | EFO_0007971 | |
| Disease | tauro-beta-muricholate measurement | 1.04e-04 | 5 | 96 | 2 | EFO_0800213 | |
| Disease | glyco-beta-muricholate measurement | 1.04e-04 | 5 | 96 | 2 | EFO_0800569 | |
| Disease | coffee consumption | 1.55e-04 | 32 | 96 | 3 | EFO_0004330 | |
| Disease | dehydroisoandrosterone sulfate DHEA-S measurement | 1.56e-04 | 6 | 96 | 2 | EFO_0021119 | |
| Disease | (N(1) + N(8))-acetylspermidine measurement | 1.56e-04 | 6 | 96 | 2 | EFO_0800091 | |
| Disease | androstenediol (3beta,17beta) monosulfate (1) measurement | 1.56e-04 | 6 | 96 | 2 | EFO_0800294 | |
| Disease | Malignant neoplasm of breast | ATP7B NRCAM CYP3A4 SLCO2B1 NUP98 ECT2 EMSY CNTN6 NAA25 SBNO1 BEND7 NUP133 | 1.91e-04 | 1074 | 96 | 12 | C0006142 |
| Disease | X-24574 measurement | 2.18e-04 | 7 | 96 | 2 | EFO_0800897 | |
| Disease | Colorectal Neoplasms | 2.96e-04 | 277 | 96 | 6 | C0009404 | |
| Disease | low density lipoprotein cholesterol measurement, alcohol consumption measurement | 3.13e-04 | 99 | 96 | 4 | EFO_0004611, EFO_0007878 | |
| Disease | low density lipoprotein cholesterol measurement, alcohol drinking | 3.50e-04 | 102 | 96 | 4 | EFO_0004329, EFO_0004611 | |
| Disease | malaria | 3.50e-04 | 102 | 96 | 4 | EFO_0001068 | |
| Disease | androstenediol (3beta,17beta) disulfate (1) measurement | 3.72e-04 | 9 | 96 | 2 | EFO_0800278 | |
| Disease | 4-androsten-3alpha,17alpha-diol monosulfate (3) measurement | 4.63e-04 | 10 | 96 | 2 | EFO_0022090 | |
| Disease | 5alpha-androstan-3beta,17alpha-diol disulfate measurement | 4.63e-04 | 10 | 96 | 2 | EFO_0800289 | |
| Disease | coronary artery disease, factor VII measurement | 4.83e-04 | 111 | 96 | 4 | EFO_0001645, EFO_0004619 | |
| Disease | DNA repair protein RAD51 homolog 4 measurement | 5.65e-04 | 11 | 96 | 2 | EFO_0801531 | |
| Disease | androstenediol (3beta,17beta) monosulfate (2) measurement | 5.65e-04 | 11 | 96 | 2 | EFO_0800295 | |
| Disease | 5alpha-androstan-3beta,17beta-diol monosulfate (2) measurement | 6.77e-04 | 12 | 96 | 2 | EFO_0800291 | |
| Disease | androstenediol (3alpha, 17alpha) monosulfate (3) measurement | 7.98e-04 | 13 | 96 | 2 | EFO_0800293 | |
| Disease | 5alpha-pregnan-3beta,20beta-diol monosulfate (1) measurement | 7.98e-04 | 13 | 96 | 2 | EFO_0800284 | |
| Disease | polyunsaturated fatty acid measurement | 8.99e-04 | 131 | 96 | 4 | EFO_0010733 | |
| Disease | X-21470 measurement | 9.29e-04 | 14 | 96 | 2 | EFO_0800817 | |
| Disease | 5alpha-androstan-3alpha,17alpha-diol monosulfate measurement | 9.29e-04 | 14 | 96 | 2 | EFO_0800283 | |
| Disease | atrophic macular degeneration, age-related macular degeneration, wet macular degeneration | 9.98e-04 | 60 | 96 | 3 | EFO_0001365, EFO_0004683, EFO_1001492 | |
| Disease | 16a-hydroxy DHEA 3-sulfate measurement | 1.07e-03 | 15 | 96 | 2 | EFO_0800301 | |
| Disease | APOE carrier status, dementia | 1.10e-03 | 62 | 96 | 3 | EFO_0007659, MONDO_0001627 | |
| Disease | X-21410 measurement | 1.22e-03 | 16 | 96 | 2 | EFO_0800813 | |
| Disease | andro steroid monosulfate C19H28O6S (1) measurement | 1.22e-03 | 16 | 96 | 2 | EFO_0800305 | |
| Disease | 5alpha-androstan-3alpha,17beta-diol monosulfate (1) measurement | 1.55e-03 | 18 | 96 | 2 | EFO_0800288 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 1.56e-03 | 152 | 96 | 4 | DOID:0060041 (implicated_via_orthology) | |
| Disease | metabolonic lactone sulfate measurement | 1.73e-03 | 19 | 96 | 2 | EFO_0800659 | |
| Disease | cerebral infarction (is_marker_for) | 1.73e-03 | 19 | 96 | 2 | DOID:3526 (is_marker_for) | |
| Disease | blood arsenic measurement | 1.73e-03 | 19 | 96 | 2 | EFO_0021527 | |
| Disease | etiocholanolone glucuronide measurement | 1.73e-03 | 19 | 96 | 2 | EFO_0800362 | |
| Disease | androsterone glucuronide measurement | 1.92e-03 | 20 | 96 | 2 | EFO_0800317 | |
| Disease | triglyceride measurement, high density lipoprotein cholesterol measurement | 2.05e-03 | 274 | 96 | 5 | EFO_0004530, EFO_0004612 | |
| Disease | serum alanine aminotransferase measurement | 2.11e-03 | 869 | 96 | 9 | EFO_0004735 | |
| Disease | schizophrenia (is_implicated_in) | 2.13e-03 | 78 | 96 | 3 | DOID:5419 (is_implicated_in) | |
| Disease | X-24947 measurement | 2.32e-03 | 22 | 96 | 2 | EFO_0800910 | |
| Disease | sex interaction measurement, bilirubin measurement | 2.32e-03 | 22 | 96 | 2 | EFO_0004570, EFO_0008343 | |
| Disease | 5alpha-androstan-3beta,17beta-diol disulfate measurement | 2.32e-03 | 22 | 96 | 2 | EFO_0021115 | |
| Disease | Hepatolenticular Degeneration | 2.76e-03 | 24 | 96 | 2 | C0019202 | |
| Disease | Dyslipidemias | 2.76e-03 | 24 | 96 | 2 | C0242339 | |
| Disease | Hepatic Form of Wilson Disease | 2.76e-03 | 24 | 96 | 2 | C1527352 | |
| Disease | Dyslipoproteinemias | 2.76e-03 | 24 | 96 | 2 | C0598784 | |
| Disease | nephrotic syndrome (biomarker_via_orthology) | 2.76e-03 | 24 | 96 | 2 | DOID:1184 (biomarker_via_orthology) | |
| Disease | epiandrosterone sulfate measurement | 2.99e-03 | 25 | 96 | 2 | EFO_0021120 | |
| Disease | Fatty Liver | 3.00e-03 | 88 | 96 | 3 | C0015695 | |
| Disease | Steatohepatitis | 3.00e-03 | 88 | 96 | 3 | C2711227 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IKGTMVSKFPVIVGH | 66 | P40394 | |
| VKMKPPVLSVAPFVA | 901 | Q9NR48 | |
| SGEAIKMFPTIKTPE | 2941 | P13611 | |
| KMFPTIKTPEAGTVI | 2946 | P13611 | |
| MFRKPIPSTVKAGEL | 1641 | Q01955 | |
| ESIPVTKTPLPKMDS | 316 | Q4VNC1 | |
| LITGEAMPVTKKPGS | 856 | P35670 | |
| KTTIFKMLTGDIIPS | 2296 | Q86UK0 | |
| PFRETITKPPKVDMV | 691 | Q7Z2Z2 | |
| VGVPNTRPVKKTMEI | 251 | Q6JQN1 | |
| TRSGAILPKPVKMSF | 51 | Q9H4I9 | |
| PGKTSVESKVPTQME | 86 | O75952 | |
| VDVKMVSGFIPLKPT | 1381 | P01023 | |
| VSGFIPLKPTVKMLE | 1386 | P01023 | |
| VVMVTKPKAVSTPAP | 71 | P54727 | |
| IVDVKMVSGFIPLKP | 1386 | P20742 | |
| KFRVAVSLGTPIMKP | 226 | Q9H8V3 | |
| VKTFGSSLPVKVMEA | 81 | Q8WUM0 | |
| TIKFNPPTGTDTMVK | 161 | P52948 | |
| PVPAKPTVLFEKMGV | 376 | Q66K74 | |
| KVVPQTVMATVPVKA | 846 | Q6P4R8 | |
| VPLSVISQPMKGKSV | 1186 | Q6P4R8 | |
| ISQPMKGKSVVTAPI | 1191 | Q6P4R8 | |
| KDPLVTMKPGTGTLI | 91 | Q92823 | |
| TFTSGKLKEMVPIIA | 136 | P08684 | |
| PGVEMTVFRKVSSTP | 116 | Q9H6A9 | |
| MDKPVFTDPPVKTKF | 106 | Q9Y237 | |
| VAQMTLTLKPKPSVG | 266 | Q14766 | |
| PSVCPLGFEVKSKMV | 4896 | Q02817 | |
| EGFVPPKVMLISSKV | 341 | Q6X4W1 | |
| PQEKTPPTTVSGKVM | 216 | Q6UWI2 | |
| IPKFLVSMATGDKTI | 76 | A6NCV1 | |
| ITVKSLPKAPGTPMV | 326 | Q13332 | |
| KMSIIPQEPVLFTGT | 1116 | O15439 | |
| TTPVAVKTLKPGSMD | 256 | P42685 | |
| TVPEIKTILGTMPAF | 2586 | P04114 | |
| GSESMKVAIVKPGVP | 41 | Q9Y4L1 | |
| VTLVAPKGPKIVMTP | 336 | Q96ID5 | |
| SEMTLVAPEIKPGKS | 2131 | Q4G0P3 | |
| GKQMVAKVPPTVTST | 1036 | Q99715 | |
| VAIKTLKPGTMSPES | 296 | P06241 | |
| KKTMTNPTTVIEVYP | 131 | A6NMD0 | |
| VKERTVITVPPSKMD | 496 | Q9UQ52 | |
| VEPLTVKQKPSGSEM | 226 | Q8N7W2 | |
| ATRPITKMIVTQPKG | 626 | Q7Z589 | |
| TFTSGKLKEMVPIIA | 136 | P24462 | |
| KALGTTVMVPVPYEK | 121 | Q86UP8 | |
| KALGTTVMVPVPYEK | 121 | Q6EKJ0 | |
| VAEIPVSAKPKGMTS | 21 | Q9H1E1 | |
| RSFSPTMKVPVVKED | 211 | A3KN83 | |
| PIKTRLIKTFPVDTM | 801 | Q9H329 | |
| TVVMKDGKVIFPAPT | 426 | Q13423 | |
| GKAGKFDIIPTMTTI | 321 | P51575 | |
| LSTVTRGSMKKVFPP | 161 | Q9NZJ7 | |
| MAFKDTGKTPVEPEV | 1 | P60866 | |
| KEMLTLPTFPVVVKI | 256 | Q92777 | |
| IPMVIFELSVPSKEI | 1516 | Q5TCS8 | |
| KGKSPPMAEATPVIV | 1316 | Q9C093 | |
| VTIGMQKFFIPKSPT | 636 | Q9NQ86 | |
| VEVFKDPAPVKTMTI | 511 | Q13275 | |
| VFLSMTPLKGIKSVI | 121 | Q6P4A7 | |
| KGIKMVSEISVPPSR | 51 | Q9H5Y7 | |
| ILKVCTKTMPIGPDV | 661 | Q9BVQ7 | |
| TGKTVAMPIKVVSVE | 446 | Q8N3T6 | |
| LPFTIISMKDTEGIP | 201 | P04053 | |
| PMGRTILKVTPEKQT | 1031 | Q7Z7B0 | |
| KPVMTTRPTAVKATG | 91 | Q8N3X1 | |
| VEVKVLTTVPEMKPQ | 1246 | P30414 | |
| VVMKIKPGISEFATS | 131 | Q9Y227 | |
| MKITVSLEIVPPKVT | 116 | Q96D42 | |
| LPIFTPAKMGATKEE | 91 | O15273 | |
| EVTPKLPKESSGIMA | 146 | Q96JW4 | |
| IGSPEKMEPITKVSH | 291 | Q6IE81 | |
| LVSPITGEKIPASKM | 411 | Q15459 | |
| KGPKADVMTPVVEVS | 4246 | Q8IVF2 | |
| MEAKTLGTVTPRKPV | 1 | Q9BW66 | |
| PTCKKIMTVLTVGIF | 346 | P48995 | |
| KKVMVLDFVTPTPLG | 186 | Q16881 | |
| MVSPVTVVKSEGPKL | 1 | Q8N2M4 | |
| SVVPVPFDIMKGLTL | 496 | Q8IYI8 | |
| MVGFKATDVPPTATV | 1 | P55851 | |
| LVLVSPGDMKKSPVT | 836 | Q5TCY1 | |
| MDSGTVLFEIKKPPV | 96 | Q13432 | |
| EVKMSGTIVKIEPPD | 226 | Q9Y5T5 | |
| EVIKESGPPHMKSFV | 226 | Q9NUL3 | |
| KAMEGIFIKPSVEPS | 201 | Q9HCN8 | |
| VPQVPDKETKATMGT | 11 | O94956 | |
| EVMTKLGFKVTLPPF | 56 | O60224 | |
| ATIKSMKEEGITFPP | 131 | O75886 | |
| VTPVSPLGKKLNVTM | 71 | Q5VY80 | |
| MEKSPKSEVVITTVP | 21 | Q9NV29 | |
| KEPVPTISSKMVTPA | 306 | Q9NRE2 | |
| TTIKVMEKPPFDRSI | 51 | Q8N392 | |
| VVVEVMKTALGPAPT | 111 | P0C7T8 | |
| VTKPVTVSRPMPVTK | 236 | Q96KM6 | |
| AMPVTKPITVTKSVP | 251 | Q96KM6 | |
| ITTPIIDTFKVPKEM | 481 | Q9H1V8 | |
| PSTLVPVVTPSEKKM | 816 | Q86VR7 | |
| THMTLTIPEFPGKLK | 271 | Q05996 | |
| MKKPHTTEEIGVPIS | 476 | Q9P275 | |
| ETQVRTPMAGVSPKK | 76 | B7Z6K7 | |
| METFEVKVDSPVKPA | 1586 | Q9P2D8 | |
| KEIMKVTGTPPAEFV | 236 | P53778 | |
| MSPVKKPAETTVGTL | 1106 | Q9NR99 | |
| KKETSIIMPPVFTSF | 876 | Q14CX7 |